Carmell Co. (NASDAQ:CTCX – Get Free Report) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 55,400 shares, a decline of 5.5% from the August 15th total of 58,600 shares. Currently, 0.4% of the shares of the stock are short sold. Based on an average trading volume of 27,300 shares, the short-interest ratio is presently 2.0 days.
Carmell Price Performance
Shares of NASDAQ CTCX opened at $0.43 on Wednesday. The business has a fifty day moving average price of $0.94 and a two-hundred day moving average price of $1.81. Carmell has a fifty-two week low of $0.43 and a fifty-two week high of $4.99.
Carmell (NASDAQ:CTCX – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.16) earnings per share for the quarter. The business had revenue of $0.01 million during the quarter.
Hedge Funds Weigh In On Carmell
Carmell Company Profile
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Featured Stories
- Five stocks we like better than Carmell
- Financial Services Stocks Investing
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Why Invest in 5G? How to Invest in 5G Stocks
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Consumer Staples Stocks, Explained
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.